Eric Casaburi - 19 Jan 2024 Form 4 Insider Report for OneMedNet Corp (ONMD)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
26 Nov 2025, 21:54:45 UTC
Prior SEC filing
26 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Robert Golden, Attorney-in-Fact

Key filing fact

Eric Casaburi filed Form 4 for OneMedNet Corp (ONMD) on 26 Nov 2025.

Key facts

  • This page summarizes Eric Casaburi's Form 4 filing for OneMedNet Corp (ONMD).
  • 9 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 26 Nov 2025, 21:54.

Change

  • Previous filing in this sequence was filed on 26 Nov 2025.
  • Current net transaction value: +$39,262.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001990853 Primary reporting owner

Casaburi Eric

Relationship
Director
Address
6385 OLD SHADY OAK ROAD, SUITE 250, EDEN PRAIRIE
Signature
/s/ Robert Golden, Attorney-in-Fact
Signature date
26 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ONMD transaction

Common Stock

Award

Transaction value
$0
Shares
+45,000
Change %
Price
$0.000000
Shares after
45,000
Date
19 Jan 2024
Ownership
Direct
Footnotes
F1
ONMD transaction

Common Stock

Purchase

Transaction value
$1,540
Shares
+2,000
Change %
+4.4%
Price
$0.7700
Shares after
47,000
Date
16 Feb 2024
Ownership
Direct
ONMD transaction

Common Stock

Purchase

Transaction value
$414
Shares
+575
Change %
+1.2%
Price
$0.7200
Shares after
47,575
Date
29 Feb 2024
Ownership
Direct
ONMD transaction

Common Stock

Purchase

Transaction value
$1,480
Shares
+2,000
Change %
+4.2%
Price
$0.7400
Shares after
49,575
Date
05 Mar 2024
Ownership
Direct
ONMD transaction

Common Stock

Purchase

Transaction value
$3,772
Shares
+4,100
Change %
+8.3%
Price
$0.9200
Shares after
53,675
Date
08 Jul 2024
Ownership
Direct
ONMD transaction

Common Stock

Purchase

Transaction value
$425
Shares
+500
Change %
+0.93%
Price
$0.8500
Shares after
54,175
Date
12 Nov 2024
Ownership
Direct
ONMD transaction

Common Stock

Purchase

Transaction value
$1,131
Shares
+1,300
Change %
+2.4%
Price
$0.8700
Shares after
55,475
Date
20 Nov 2024
Ownership
Direct
ONMD transaction

Common Stock

Purchase

Transaction value
$30,500
Shares
+10,000
Change %
+18%
Price
$3.05
Shares after
65,475
Date
15 Oct 2025
Ownership
Direct
ONMD transaction

Common Stock

Award

Transaction value
$0
Shares
+45,000
Change %
+69%
Price
$0.000000
Shares after
110,475
Date
26 Nov 2025
Ownership
Direct
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan (the "2022 Plan") for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vested on December 31, 2024.

Footnote F2

Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .